Amphastar 制药 AMPH
$28.49 +$0.83 (+3.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $28.49 0.00%
开盘$29.44
昨收$27.66
当日区间$27.80 – $31.00
成交量826.3K
市值$1.22B
市盈率（TTM）13.1
股息率–
AMPH 相关新闻
匹配 Amphastar Pharmaceuticals 或代码 AMPH 的头条新闻，按最新排序。
- Wells Fargo Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $20 正面
- Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $20
- Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 负面
- Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Raises Target Price to $23 正面
- Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating
- Amphastar Pharmaceuticals (AMPH) Gets a Hold From J.P. Morgan
- Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $20 负面
- Analysts Offer Insights on Healthcare Companies: CVRx (CVRX), Ardent Health Partners, Inc. (ARDT) and Amphastar Pharmaceuticals (AMPH)
- BofA Securities Downgrades Amphastar Pharmaceuticals(AMPH.US) to Sell Rating, Cuts Target Price to $20 负面
- Analysts Offer Insights on Healthcare Companies: Caris Life Sciences, Inc. (CAI), Amphastar Pharmaceuticals (AMPH) and Amylyx Pharmaceuticals Inc (AMLX)
- Needham Downgrades Amphastar Pharmaceuticals(AMPH.US) to Hold Rating 负面
- Wells Fargo Initiates Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Announces Target Price $19
- Piper Sandler Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $21 负面
- Barclays Maintains Amphastar Pharmaceuticals(AMPH.US) With Hold Rating, Cuts Target Price to $23 负面
- Needham Maintains Amphastar Pharmaceuticals(AMPH.US) With Buy Rating, Maintains Target Price $30
暂无评论——快来第一个聊聊 AMPH。